-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-555-09-03-2013.pdf
January 01, 2013 - amputation, blindness,
cardiovascular outcomes (e.g., heart disease, stroke), comorbidities (e.g., depression
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ocd-protocol.pdf
August 15, 2023 - quality of life,
particularly in academic and social functioning.4-6 Untreated OCD is associated with depression … ability to describe their experiences.1, 11, 12 Furthermore, OCD
in children is often comorbid with depression … behavior
• Columbia Suicide Severity Rating Scale Recent
Self-Report Screener (C-SSRS)
Anxiety and depression … Form
QoL Quality of life
RCT Randomized controlled trial
RCADS-25 Revised Children’s Anxiety and Depression
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
April 01, 2022 - differences in pain improvement
and pain response between the
two formulations; sleep, anxiety,
depression … no differences between pregabalin formulations on DPRS 30 and 50 percent
pain reduction, sleep, and depression … 0.001).9 There was also no
difference between pregabalin versus placebo on the Hospital Anxiety and Depression … Scale
(HADS) anxiety scale, but pregabalin was associated with improved HADS depression score
(p=0.02 … Comparing duloxetine and
pregabalin for treatment of pain and
depression in women with fibromyalgia
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-agitation-aggression_research-protocol.pdf
November 13, 2014 - but these are more prevalent in advanced stages.7 Symptoms often
occur in clusters and can include depression … specific.18 General measures evaluate a host of behaviors across various domains
(e.g., agitation, depression … specific behavioral instruments evaluate a single behavioral domain (e.g., only
agitation, or only depression … of the
association between individual patient behavioral and psychological symptoms and caregiver
depression
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2021.pdf
January 01, 2021 - Systematic
Review Update
Why: Urinary Incontinence (UI) increases morbidity, such as
risks for depression … Anxiety, depression, and quality of life after procedural
intervention for uterine fibroids. … Outcome Measure Harmonization and Data
Infrastructure for Patient-Centered Outcomes Research in Depression … Agenda for Using the Harmonized
Outcome Measures to Support Patient-Centered Outcomes Research in Depression
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-276-ocd-appendix-h.xlsx
January 01, 2023 - restructuring, ERP/Exposure ERP Yes Yes 3 48 Adequate OCD symptom severity CY-BOCS (continuous) reduction Depression … ERP/Exposure CBT Yes Yes 4 25 Adequate OCD symptom severity CY-BOCS (continuous) postreatment score Depressive … symptom severity (BDI-Y) higher vs lower beta 0.02 NS NS Neutral (Nonsignificant)
25301176 Brown … Exposure CBT Yes Yes 4 25 Adequate OCD symptom severity CY-BOCS (continuous) postreatment score Comorbid depression … Exposure CBT Yes Yes 4 15 Adequate OCD symptom severity CY-BOCS (continuous) postreatment score Comorbid depression
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-measures-framework_research.pdf
April 01, 2010 - Feasibility/usability:
38% of cancer
patients met
criteria, multiple
hospitals
UHC18
Psychiatric Depression … IF depression is diagnosed in a cancer
patient, THEN a treatment plan for depres-
sion should be documented … BECAUSE
there are a variety of effective approaches to
treating depression associated with cancer. … Process
Communication and
decisionmaking
Continuity and coordination
Utilization
Depression
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-framework_research.pdf
April 01, 2010 - Feasibility/usability:
38% of cancer
patients met
criteria, multiple
hospitals
UHC18
Psychiatric Depression … IF depression is diagnosed in a cancer
patient, THEN a treatment plan for depres-
sion should be documented … BECAUSE
there are a variety of effective approaches to
treating depression associated with cancer. … Process
Communication and
decisionmaking
Continuity and coordination
Utilization
Depression
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-adhd-prescription-rapid-research.pdf
July 01, 2025 - prescription stimulant misuse was significantly associated with past-year diagnosis or treatment
of depression … ADHD, depression, and substance abuse risk
among beginning college students. … of administration: NR
Health: NR
Psychological:
Nonmedical ADHD
stimulants users, Past-
year: Depression … Symptoms of
anxiety and depression
were not statistically
significant in the model
Polysubstance … Of students who misused 77.6%
reported a lifetime psychiatric
diagnosis (depression, anxiety, or
bipolar
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/fibromyalgia_research-protocol.pdf
April 03, 2014 - processing/heightened pain sensitivity, chronic fatigue, sleep disorders, and emotional distress or
depression … studies identified modest differences by sex in
clinical features (pain sensitivity, tender point count, depression … conditions: Coexisting mental health disorders are
particularly common in fibromyalgia patients, especially depression … , anxiety and substance
abuse.26 Depression and/or anxiety occur in over one-third of fibromyalgia patients … Gender
differences in pain severity, disability, depression, and widespread pressure pain sensitivity
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
March 22, 2016 - conditions are associated
with an increased risk of developing MCI and Alzheimer’s disease, including depression … and control of chronic medical
or mental health conditions (i.e., cardiovascular disease, obesity, depression … interventions)
Cognitive stimulation and training
Community-level interventions (built environment)
Depression … We will examine
how treatment for depression affects the cognitive decline.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/glucocorticoid-injections_clinician.pdf
June 01, 2016 - glucocorticoids
plus lidocaine also reported greater
treatment satisfaction and greater re-
ductions in depressive … symptoms.
»» Transforaminal injections of glucocorti-
coids plus lidocaine showed no signifi-
cant
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
January 01, 2023 - Median 65 64 NR NR NR NR NR Median 60 Patients with severe
psychiatric diseases (severe depression and … Scale Assessment Time (Weeks) for Depression Variance Type for Depression Intervention A, Baseline N … B, Followup Lower Limit Intervention B, Followup 95% CI Upper Limit Intervention C, N Analyzed for Depression … scale- anxiety; HADS-D = hospital anxiety and depression scale- depression; HIV = human immunodeficiency … survey; THC = tetrahydrocannabinol; VAS = visual analog scale; ZAS = Zung anxiety scale; ZDS = Zung depression
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
January 01, 2023 - Median 65 64 NR NR NR NR NR Median 60 Patients with severe
psychiatric diseases (severe depression and … Scale Assessment Time (Weeks) for Depression Variance Type for Depression Intervention A, Baseline N … B, Followup Lower Limit Intervention B, Followup 95% CI Upper Limit Intervention C, N Analyzed for Depression … scale- anxiety; HADS-D = hospital anxiety and depression scale- depression; HIV = human immunodeficiency … survey; THC = tetrahydrocannabinol; VAS = visual analog scale; ZAS = Zung anxiety scale; ZDS = Zung depression
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
January 01, 2022 - Median 65 64 NR NR NR NR NR Median 60 Patients with severe
psychiatric diseases (severe depression and … Scale Assessment Time (Weeks) for Depression Variance Type for Depression Intervention A, Baseline N … B, Followup Lower Limit Intervention B, Followup 95% CI Upper Limit Intervention C, N Analyzed for Depression … scale- anxiety; HADS-D = hospital anxiety and depression scale- depression; HIV = human immunodeficiency … survey; THC = tetrahydrocannabinol; VAS = visual analog scale; ZAS = Zung anxiety scale; ZDS = Zung depression
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ehc-research-gaps-telehealth.pdf
April 01, 2023 - provide benefits for in patient care, for neonates in
rural hospitals, outpatient management of
depression … with usual care, telehealth interventions
for IPV services resulted in similar rates of repeat
IPV, depression
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-207-ptsd-disposition-comments.pdf
May 17, 2018 - Comment Response
Peer Reviewer 1 Methods Figure 19 (page 70) reports the findings for change in
depression … Peer Reviewer 3 Results p. 48: Table 6, ref. 44 for cognitive therapy is listed in the
CPT row for depression … Peer Reviewer 3 Results Also, why aren’t the depression data being reported in the
summary tables? … We do report information on depression differences in
summary tables. … Finally, as reported in Huhn2, in the research literature for
treatment of depression, the effect size
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_clinician.pdf
May 01, 2011 - include
habituation, alterations in mental status, nausea and vomiting,
constipation, and respiratory depression
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-protocol.pdf
July 10, 2018 - 13 Other recent RCTs address new or emerging
interventions, such as pharmacotherapies effective for depression … Comorbid diagnoses required for study entry
n. % Treatment naïve*
o. % with depression*
p. % with … Results for all reported depression outcomes
o. Results for all reported anxiety outcomes
p.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-protocol.pdf
July 10, 2018 - 13 Other recent RCTs address new or emerging
interventions, such as pharmacotherapies effective for depression … Comorbid diagnoses required for study entry
n. % Treatment naïve*
o. % with depression*
p. % with … Results for all reported depression outcomes
o. Results for all reported anxiety outcomes
p.